Latest Interviews

CONSYNANCE THERAPEUTICS

"Although each rare disease impacts a small population, the rare disease population is estimated to be 10% of the total population, meaning 25-30 million Americans have at least one rare condition."

AC IMMUNE

"AC Immune is combining diagnostics and therapeutics, and it has developed the tools to enable detection and clearance of specific pathological proteins underlying neurodegenerative diseases."

TRADEASIA INTERNATIONAL GROUP

"Digital platforms for industrial chemicals are becoming more and more important as the world embraces digital engagement in every sphere of our life."

"At Vyant Bio we are reinventing how drugs are discovered for complex neurological and neurodegenerative disorders by applying a human-first approach."

MITSUI CHEMICALS ASIA PACIFIC (MCAP)

"MCAP is committed to continue our support to Mitsui Chemicals Group in moving towards a solution-based business model to respond to social and environmental challenges."

LARA CONSULTING

“Hoy día, los equipos se están aduecuando cada vez más a las condiciones de sitio, a la creciente producción minera, a relaves cada vez más finos, y a mayores cuidados ambientales, no solamente para producir y/o ubicar estos depósitos de relaves, sino para la gestión de riesgos de estas instalaciones.”